HOERTKORN RICHARD CHARLES - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
HOERTKORN RICHARD CHARLES ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2020$109,000
-21.6%
4,0500.0%0.06%
-34.8%
Q3 2020$139,000
-16.3%
4,0500.0%0.09%
-18.6%
Q2 2020$166,0004,0500.11%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders